Publications by authors named "Pierre Gestraud"

Claim this Profile
M
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, Zoé Nevière, Pierre Gestraud

Lancet Reg Health Eur· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.
Abderaouf Hamza, Pierre Gestraud, Maryam Karimi, Alicia Tran-Dien, Laurène Syx

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of microprotein-coding intronic polyadenylation isoforms and function in genotoxic anticancer drug response.
Alexandre Devaux, Iris Tanaka, Quentin Fouilleul, Amélie Heneman-Masurel, Mandy Cadix, Pierre Gestraud

Genome Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, Constance Lamy, Magali Lacroix-Triki

Br J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet, Pierre Gestraud

NPJ Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated High-Throughput Screening and Large-Scale Isobolographic Analysis to Accelerate the Discovery of Radiosensitizers With Greater Selectivity for Cancer Cells.
Pierre Verrelle, Pierre Gestraud, Florent Poyer, Adèle Soria, Sarah Tessier

Int J Radiat Oncol Biol Phys· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation restricts coordinated germline and neural fates in embryonic stem cell differentiation.
Mathieu Schulz, Aurélie Teissandier, Elena De La Mata Santaella, Mélanie Armand, Julian Iranzo, Pierre Gestraud

Nat Struct Mol Biol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A druggable copper-signalling pathway that drives inflammation.
Stéphanie Solier, Sebastian Müller, Tatiana Cañeque, Antoine Versini, Arnaud Mansart, Pierre Gestraud

Nature· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.
Elizabeth R Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Pierre Gestraud

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics to select treatment for patients with metastatic breast cancer.
Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, Pierre Gestraud

Nature· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation.
Kenza Nedara, Camille Reinhardt, Emilie Lebraud, Giuseppe Arena, Céline Gracia, Pierre Gestraud

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A catalog of numerical centrosome defects in epithelial ovarian cancers.
Jean-Philippe Morretton, Anthony Simon, Aurélie Herbette, Jorge Barbazan, Carlos Pérez-González, Pierre Gestraud

EMBO Mol Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome.
Alice Mogenet, Fabrice Barlesi, Benjamin Besse, Stefan Michiels, Maryam Karimi, Pierre Gestraud

Lung Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin.
Alina Chakraborty, Mandy Cadix, Sébastien Relier, Nicolò Taricco, Tina Alaeitabar, Pierre Gestraud

Genome Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia.
Justine Decroocq, Rudy Birsen, Camille Montersino, Prasad Chaskar, Jordi Mano, Pierre Gestraud

Leukemia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 T1 cell response.
Aurélien Sutra Del Galy, Silvia Menegatti, Jaime Fuentealba, Francesca Lucibello, Laetitia Perrin, Pierre Gestraud

Sci Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial.
Célia Dupain, Julien Masliah-Planchon, Céline Gu, Elodie Girard, Pierre Gestraud

Mol Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Suzy M Scholl, Jonas Beal, Leanne de Koning, Elodie Girard, Marina Popovic, Pierre Gestraud

EBioMedicine· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, Elodie Girard, Sylvain Dureau, Pierre Gestraud

EBioMedicine· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human chromosome-specific aneuploidy is influenced by DNA-dependent centromeric features.
Marie Dumont, Riccardo Gamba, Pierre Gestraud, Sjoerd Klaasen, Joseph T Worrall

EMBO J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CCR5 trafficking to inhibit HIV-1 infection.
Gaelle Boncompain, Floriane Herit, Sarah Tessier, Aurianne Lescure, Elaine Del Nery, Pierre Gestraud

Sci Adv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, Elodie Girard, Sylvain Dureau, Pierre Gestraud

EBioMedicine· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Abiraterone Acetate Efficacy in Androgen Receptor-positive Triple-negative Breast Cancer: Chk1 as a Potential Target.
Thomas Grellety, Celine Callens, Elodie Richard, Adrien Briaux, Valérie Vélasco, Pierre Gestraud

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels.
Benjamin Sadacca, Anne-Sophie Hamy, Cécile Laurent, Pierre Gestraud, Hélène Bonsang-Kitzis

Sci Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels.
Benjamin Sadacca, Anne-Sophie Hamy, Cécile Laurent, Pierre Gestraud, Hélène Bonsang-Kitzis

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis